These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32525607)

  • 1. Hepatocellular Carcinoma in the COVID-19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?
    Scorsetti M; Goodman KA; Seong J; Loi M; Huguet F; Dawson LA
    Oncologist; 2020 Aug; 25(8):e1249-e1250. PubMed ID: 32525607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential benefit of rotational radiation therapy.
    Vickress J; Lock M; Lo S; Yartsev S
    Future Oncol; 2017 Apr; 13(10):873-874. PubMed ID: 28067056
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
    McPartlin AJ; Dawson LA
    Cancer J; 2016; 22(4):296-301. PubMed ID: 27441750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for Hepatocellular Carcinoma.
    Yu Y; Feng M
    Semin Radiat Oncol; 2018 Oct; 28(4):277-287. PubMed ID: 30309638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Severe Cirrhosis and Ineligibility for Transplant.
    Valakh V; Gresswell S; Kirichenko A
    Anticancer Res; 2018 Dec; 38(12):6815-6820. PubMed ID: 30504395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-therapeutics features of hepatocellular carcinoma treated by stereotactic body radiation therapy].
    Oldrini G; Vogin G; Renard-Oldrini S; Taste-George H; Grignon B; Henrot P
    Presse Med; 2015 Sep; 44(9):951-3. PubMed ID: 26358674
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Soni PD; Palta M
    Dig Dis Sci; 2019 Apr; 64(4):1008-1015. PubMed ID: 30868409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial: The jury is still out.
    Duan L; Yang L; Zhang B; Liao J; Zheng X
    Eur J Cancer; 2022 Oct; 174():310-312. PubMed ID: 35933258
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to letter entitled: Re: 'Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial'.
    Shi C; Li Y; Geng L; Shen W; Sui C; Dai B; Lu J; Pan M; Yang J
    Eur J Cancer; 2022 Oct; 174():313-314. PubMed ID: 35863939
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
    Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.
    Bae SH; Kim MS; Jang WI; Kay CS; Kim W; Kim ES; Kim JH; Kim JH; Yang KM; Lee KC; Chang AR; Jo S
    Jpn J Clin Oncol; 2016 Apr; 46(4):363-9. PubMed ID: 26826720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.
    Meyer J; Singal AG
    Liver Transpl; 2018 Mar; 24(3):420-427. PubMed ID: 29205797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints.
    Park S; Yoon WS; Rim CH
    World J Gastroenterol; 2020 Jan; 26(4):393-403. PubMed ID: 32063688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.
    Nakano R; Ohira M; Kobayashi T; Ide K; Tahara H; Kuroda S; Shimizu S; Kimura T; Nagata Y; Aikata H; Chayama K; Ohdan H
    Surgery; 2018 Aug; 164(2):219-226. PubMed ID: 29801728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
    Mitin T; Degnin C; Chen Y; Shirvani S; Gillespie E; Hoffe S; Latifi K; Nabavizadeh N; Dengina N; Chernich M; Usychkin S; Kharitonova E; Egorova Y; Pankratov A; Tsimafeyeu I; Thomas CR; Tjulandin S; Likhacheva A
    J Cancer Educ; 2020 Feb; 35(1):105-111. PubMed ID: 30467774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological concerns for investigating the effects of mid-treatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC).
    Kibe Y; Takeda A
    Radiother Oncol; 2020 Jun; 147():234. PubMed ID: 32178853
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Kibe Y et al. "Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)".
    Jackson WC; Cuneo KC; Lawrence TS; Schipper MJ; Owen D
    Radiother Oncol; 2020 Jun; 147():235. PubMed ID: 32253019
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and hepatocellular carcinoma: update and review of the literature.
    Ursino S; Greco C; Cartei F; Colosimo C; Stefanelli A; Cacopardo B; Berretta M; Fiorica F
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1599-604. PubMed ID: 23111978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.